InvestorsHub Logo
Post# of 596784
Next 10
Followers 2543
Posts 250731
Boards Moderated 34
Alias Born 05/06/2014

Re: None

Friday, 05/27/2016 12:20:00 AM

Friday, May 27, 2016 12:20:00 AM

Post# of 596784
$PMCB Austrianova’s former Chief Scientist, Lilli Brandtner, features in an article about using Austrianova’s cell encapsulation technology to treat diabetes. Dr Brandtner is working together with Austrianova, PharmaCyte Inc. and other partners as part of PharmaCyte’s International Diabetes Consortium



http://themavorarlberg.at/made-in-vorarlberg/diabetes-heilen

Translation -

Cure Diabetes !

With this ambitious target is currently employs a team of researchers from around the world in a unique project . It is headed by the Vorarlberg scientist Dr. Eva Maria ( Lilli ) Brandtner from the molecular biology laboratory VIVIT in Dornbirn . Together they tried to protect insulin-producing cells from an immune attack to transplant - thereby curing type 1 diabetes would be possible to even have no intact insulin producing cells more and therefore repeatedly have to rely on insulin injections daily . Brandtner are in the " Long Night of Research " on April 22, an exclusive insight into the EU-funded project .

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.